Bioptamers (Pre-Seed)
Funding Details
Date Award
May 13, 2024
Vertical
Human Health
Company Info
Founders
Erika de Simone Molina, Emerson Moretto
Location
United States
Company Description

At Bioptamers, we spot the molecular differences between tumor cells and healthy cells and create personalized molecules to deliver chemo- and radio- immunotherapies. Our platform develops molecules that selectively bind to the patient’s cancer cells, allowing personalized precision therapies.